Food and Drug Administration
Vaccines and Related Biological Products Advisory Committee
May 21, 2002
Briefing Information
Sponsor
Disclaimer
The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.
Letter to Dr Jody Sachs releasing briefing information without redaction, Jack D Love, Worldwide Regulatory Affairs pdf
Prevnar™ , Pneumococcal Conjugate Vaccine 7-valent, for the Prevention of Acute Otitis Media doc
Attachment C: FDA Statistical Review and Evaluation pdf
Finnish AOM Study pdf
Appendix 4: References doc
Bibliography doc